LAGIPRA peptide TFA
LAGIPRA peptide TFA is a long-acting GIP1R agonist. It improves insulin sensitivity by enhancing glucose processing and reducing circulating branched-chain amino acids (BCAA) and keto acids. LAGIPRA peptide TFA shows potential for research in type 2 diabetes.
Product Specifications
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog